Credits: Canva
Women are often told not to focus on weight loss if they go to the gym. There is a preconceived notion that lifting weights can turn them into a bodybuilder. They will become too muscular and lose out on the "femininity" of their body. But is that the case? To break this myth, we spoke to a Fitness trainer, health coach and nutritionist Apar Jain.
"Weight training offers numerous health benefits for women, from improved strength and muscle tone to better bone density and metabolism," says Jain. He also points out that women do not "bulk up" like male bodybuilders and one of the reasons for that is their hormones.
Men generally have higher levels of testosterone, a hormone that also promotes muscle growth, whereas the levels are much less in women. "So even with regular weight training, they are more likely to build lean, toned muscle, rather than large, bulky ones," he explains.
Myth of Bulking: Jain explains that many women worry that lifting weights will make them bulky, but in reality, it helps them achieve a toned, athletic look. It also helps them create a leaner, more defined body by reducing body fat and increasing lean muscle mass.
"So, is it bad for women to weight train? Absolutely not! Weight training is one of the best
things women can do for their bodies, supporting overall health, longevity, and confidence. The key is to train with a balanced routine that includes both strength and cardiovascular exercise, along with a nutritious diet that supports personal fitness goals," he explains.
Addressing this preconceived notion, Jain says that media portrayals of bodybuilding have often shown men and women with extreme muscular physiques. Many people thus associate any kind of weightlifting with this look. "They are unaware of the specialised training and dietary practices that bodybuilders follow. This visibility makes women worry that lifting weight will quickly lead to a similar physique."
Historical Fitness Stereotypes: For decades, fitness marketing for women emphasised “slimness” and “toning” without muscle growth. Women were encouraged to stick to cardio or light weights with high reps, reinforcing the idea that lifting heavier weights would somehow “masculinise” their bodies. These stereotypes have taken time to fade as fitness knowledge has evolved.
Biology Misunderstandings: Many people don’t fully understand how muscle growth works or the role hormones like testosterone play. Women naturally have lower levels of testosterone than men, so they’re not biologically predisposed to gain large amounts of muscle mass. But without a solid understanding of this, many assume that lifting heavy weights alone will lead to “bulking up.”
Misleading Fitness Advice: Some fitness advice still focuses on the idea of “toning” muscles by lifting very light weights. However, muscle definition actually comes from a balance of strength training, cardiovascular exercise, and diet, rather than avoiding heavy weights. This misconception has led many women to avoid weight training altogether or stick to very low weights, reinforcing the fear of bulking.
Social Pressure and Body Image: Cultural pressures around femininity have often emphasised a lean, slim look, leading some women to avoid weight training for fear of appearing too muscular or “unfeminine.” Even as body positivity and strength are increasingly celebrated, the old biases about how women “should” look still linger.
Lack of Education and Exposure: Many women may not have access to accurate information or the support of knowledgeable trainers who can explain the benefits of weight training without bulk. As more women gain exposure to strength training and see results for themselves, this myth is starting to break down.
Credit: AP Photos
A 38-year-old US nurse practitioner has completed seven marathons while pregnant with her first child, raising questions about the safety of intense exercise during pregnancy.
Deirdre Keane, who works at Memorial Sloan Kettering Cancer Center, had completed more than 60 marathons before taking on the World Marathon Majors.
She discovered she was pregnant after noticing a slower pace during the Tokyo Marathon in March. After receiving clearance from her obstetrician-gynaecologist (OB-GYN), she decided to continue racing.
The World Marathon Majors include races in Tokyo, Boston, London, Sydney, Berlin, Chicago and New York.
Keane had initially signed up for 11 events, including seven major marathons, a trail marathon, two ultramarathons and an Ironman competition.
After discovering her pregnancy, she dropped the Ironman and one ultramarathon and agreed to take the Ireland marathon slowly.
She completed the New York City Marathon in just over four hours at 34 weeks of pregnancy, averaging 9 minutes and 26 seconds per mile, according to New York Road Runners. She had finished the same race in just over three hours in 2025.
"I knew how bizarre it was to be running a marathon at 34 weeks, but I also knew how fit I was and self-aware of my body at this point," Keane told The Associated Press.
Her doctor advised her to monitor her nutrition and hydration and stop exercising at the first sign of muscle cramping, according to the World Running Network.
"I want to teach my son resilience and that he can do hard things," she said.
Exercise is generally safe during an uncomplicated pregnancy. However, the intensity and type of activity matter.According to the American College of Obstetricians and Gynecologists (ACOG), women with healthy pregnancies can continue or begin regular physical activity after consulting their OB-GYN.
Women who regularly performed vigorous aerobic exercise before pregnancy may also be able to continue with medical approval.
However, research on prolonged, high-intensity activities such as marathon running during pregnancy remains limited.
ACOG recommends at least 150 minutes of moderate-intensity aerobic activity every week for pregnant women without medical or obstetric complications. Brisk walking and gardening are examples.
How Can Exercise Benefit The Mother And Baby?
Regular physical activity during pregnancy can:
However, these benefits do not mean strenuous exercise is suitable for every pregnant woman. Consult an OB-GYN before starting or continuing an intense workout routine.
ACOG recommends the following precautions:
Pregnant women should avoid activities that increase the risk of falls, abdominal injuries or overheating, including:
ACOG advises pregnant women to stop exercising and contact their OB-GYN if they experience:
Credit: AI-generated image
What happens when people stop taking GLP-1 weight-loss injections like Ozempic, Wegovy or Mounjaro? Do they regain weight, switch to another medication or consider bariatric surgery?
A new study published in The Lancet's eClinicalMedicine examined that what people do after their initial GLP-1 treatment can make a significant difference in their long-term weight outcomes.
Researchers at Cleveland Clinic examined health records from 20,486 patients who had taken semaglutide or tirzepatide injections for at least three months.
They compared five weight loss maintenance over a two-year period: continuing the original weight loss medication, switching between the two drugs, moving to another obesity medication, undergoing bariatric surgery or stopping treatment altogether without pursuing another option.
After two years, the average weight reductions were:
These results indicate that discontinuing GLP-1 treatment does not mean all the lost weight will come back. But patients who stopped treatment without another medical or surgical intervention experienced the lowest success in keeping the weight off.
The study also found that the outcomes of switching depended on which medication patients were taking initially. Those who moved from semaglutide to tirzepatide lost more weight than those who continued semaglutide. However, among people initially taking tirzepatide, remaining on the medication led to greater weight loss than switching to semaglutide.
Also read: Stopping Ozempic or Wegovy May Double Your Risk Of Heart Attack, Death
Not just weight loss, the findings also covered metabolic outcomes as patients with existing health conditions also showed significant differences.
Among participants with type 2 diabetes, bariatric surgery proved to drive major improvement in HbA1c. This was followed by switching between semaglutide and tirzepatide, continuing the original medication and moving to another obesity drug.
Patients with hypertension who continued treatment also experienced greater reductions in blood pressure than those who stopped.
Those who discontinued treatment without another intervention showed the smallest improvements in blood glucose control and blood pressure.
GLP-1 medications have become increasingly popular for managing diabetes and combating obesity, but long-term treatment can be difficult for some patients to maintain.
Cost, insurance and side effects are among the reasons why people may discontinue these medicines. Gastrointestinal symptoms like nausea, vomiting, diarrhoea and constipation can also affect adherence to treatment.
People who cannot continue their original medication, and are considering switching to another treatment or considering bariatric surgery should discuss their options with their healthcare providers.
Lead author Hamlet Gasoyan, a researcher at Cleveland Clinic's Center for Value-Based Care Research, said, “The encouraging news is that, for patients who need to stop their injectable GLP-1 medication, it does not mean that their obesity treatment journey has to end.”
Co-author Ali Aminian, director of Cleveland Clinic's Bariatric and Metabolic Institute, added, “When a patient stops a GLP-1 medication, the most important question is what comes next.”
He noted that patients who stopped all treatment had the least weight loss while those who moved on to another therapy, particularly bariatric surgery, did significantly better.
Credit: iStock
For years, body mass index (BMI) has been a key health marker to track obesity. But a recent study suggests that not everyone classified as obese based on their BMI may have obesity-related health problems. Researchers say just considering BMI alone may lead to incorrect diagnosis in some people while overlooking others with excess body fat and related health risks.
The international study, involving more than 844,000 adults across China, the UK, the US and Spain, supports a different approach that considers body fat distribution, waist measurement and the impact of excess fat on organ function.
Researchers propose distinguishing between two categories: pre-clinical obesity, in which excess body fat increases health risks but has not impaired organ function, and clinical obesity, in which excess fat is already affecting the body's ability to function.
BMI is calculated by dividing a person's weight in kilograms by their height in metres squared. It is used to classify people as underweight, normal weight, overweight or obese.
However, BMI does not directly measure body fat or show where fat is distributed. It also cannot distinguish between fat and muscle mass. Consequently, two people with the same BMI may have very different body compositions and health risks.
The researchers found that adding waist circumference and waist-to-height ratio to BMI helped identify people whose excess body fat might otherwise be missed.
The analysis suggested that BMI alone missed obesity level body fat in up to 8.6% of participants, while incorrectly classifying up to 3.1% as having obesity in the study groups.
Professor Francesco Rubino, senior author of the study and Chair of Metabolic and Bariatric Surgery at King's College London, said, “Body mass index alone cannot tell us whether someone is already ill or at risk of illness, or what care they need, leaving people vulnerable to both undertreatment and overtreatment.”
Also read: Loud Snoring Is Not Always Harmless: Sleep Apnoea can Become a Stroke-Risk Concern
The researchers used a framework proposed by the Lancet Diabetes and Endocrinology Commission in 2025. It separates obesity into two categories based on whether excess body fat has affected a person's health.
The study estimated that only around 23% to 31% of people classified as having obesity across the four study populations had clinical obesity. This represented approximately 5.6% to 10.9% of the overall adult populations studied.
The researchers followed participants over time to examine how often pre-clinical obesity progressed to clinical obesity.
They found that approximately 77% to 91% of people classified as having pre-clinical obesity did not progress to clinical obesity over 10 years. However, progression rates differed across the study populations.
Clinical obesity was linked with a higher risk of death while pre-clinical obesity had a more modest increase in risk.
Professor Rubino said, “Preclinical obesity should therefore be neither treated automatically as active disease nor dismissed as harmless. Some people may need preventive treatment, but its intensity should match their individual risk.”
The findings do not mean that people with pre-clinical obesity should ignore excess body fat. Rather, they highlight the importance of assessing individual health risks instead of making treatment decisions based on BMI alone.
People with excess body fat may still benefit from lifestyle hanges, treatment and preventive care even if they have not developed organ dysfunction.
© $2026 Times Horizon Private Limited